Vivani Medical, Inc. (VANI)
NASDAQ: VANI · Real-Time Price · USD
1.170
-0.080 (-6.40%)
At close: Feb 12, 2026, 4:00 PM EST
1.190
+0.020 (1.70%)
After-hours: Feb 12, 2026, 7:16 PM EST
Vivani Medical Employees
Vivani Medical had 37 employees as of December 31, 2024. The number of employees decreased by 7 or -15.91% compared to the previous year.
Employees
37
Change (1Y)
-7
Growth (1Y)
-15.91%
Revenue / Employee
n/a
Profits / Employee
-$703,405
Market Cap
93.43M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 37 | -7 | -15.91% |
| Dec 31, 2023 | 44 | -6 | -12.00% |
| Dec 31, 2022 | 50 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Agenus | 316 |
| Artiva Biotherapeutics | 106 |
| Verrica Pharmaceuticals | 71 |
| Precision BioSciences | 67 |
| Biomea Fusion | 42 |
| Equillium | 35 |
| Cognition Therapeutics | 28 |
| Oncolytics Biotech | 28 |
VANI News
- 14 days ago - Vivani Subsidiary Cortigent Presents Promising 6-Year Early Feasibility Study Results for the Orion System at NANS 2026 - GlobeNewsWire
- 16 days ago - Vivani Medical, Inc. Announces Closing of Common Stock Offering - GlobeNewsWire
- 17 days ago - Vivani Medical, Inc. Announces Pricing of Common Stock Offering - GlobeNewsWire
- 3 months ago - Vivani Medical Provides Business Update and Reports Third Quarter 2025 Financial Results - GlobeNewsWire
- 4 months ago - Vivani Medical Withdraws Record Date for Cortigent Neuromodulation Subsidiary Spin-Off - GlobeNewsWire
- 5 months ago - Vivani Medical to Present at the Emerging Growth Conference on September 25, 2025 - GlobeNewsWire
- 5 months ago - Vivani Medical Announces Record Date for Spin-off of Cortigent Neuromodulation Subsidiary to Shareholders - GlobeNewsWire
- 5 months ago - Vivani Medical Provides Update on Clinical Development Plans for NPM-139 Semaglutide Implant for Chronic Weight Management - GlobeNewsWire